Literature DB >> 16923049

A case of schizophrenia with complete agenesis of the corpus callosum.

Dhamodharan Chinnasamy1, Rebecca Rudd, Dennis Velakoulis.   

Abstract

OBJECTIVE: To describe the case of a person with schizophrenia and agenesis of the corpus callosum.
CONCLUSION: A 24-year-old Caucasian woman with schizophrenia was incidentally found to have complete agenesis of the corpus callosum. A comprehensive neuropsychiatric assessment allowed management to be specifically tailored to the patient's unique clinical profile.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923049     DOI: 10.1080/j.1440-1665.2006.02299.x

Source DB:  PubMed          Journal:  Australas Psychiatry        ISSN: 1039-8562            Impact factor:   1.369


  4 in total

1.  Genetic and functional analyses identify DISC1 as a novel callosal agenesis candidate gene.

Authors:  Nathan Osbun; Jiang Li; Mary C O'Driscoll; Zoe Strominger; Mari Wakahiro; Eric Rider; Polina Bukshpun; Elena Boland; Cailyn H Spurrell; Wendy Schackwitz; Len A Pennacchio; William B Dobyns; Graeme C M Black; Elliott H Sherr
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

2.  Diffusion abnormalities and reduced volume of the ventral cingulum bundle in agenesis of the corpus callosum: a 3T imaging study.

Authors:  Y Nakata; A J Barkovich; M Wahl; Z Strominger; R J Jeremy; M Wakahiro; P Mukherjee; E H Sherr
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-26       Impact factor: 3.825

3.  Proteome dynamics during postnatal mouse corpus callosum development.

Authors:  Alexander I Son; Xiaoqin Fu; Fumikazu Suto; Judy S Liu; Kazue Hashimoto-Torii; Masaaki Torii
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

4.  Sensory input is required for callosal axon targeting in the somatosensory cortex.

Authors:  Ying Huang; Ning-Ning Song; Wei Lan; Qiong Zhang; Ling Zhang; Lei Zhang; Ling Hu; Jia-Yin Chen; Chun-Jie Zhao; Lingjiang Li; Lin Xu; Yu-Qiang Ding
Journal:  Mol Brain       Date:  2013-12-05       Impact factor: 4.041

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.